×
TruBridge EBITDA 2010-2025 | TBRG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
TruBridge ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
TruBridge EBITDA 2010-2025 | TBRG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
TruBridge ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$47.6B
Hims & Hers Health (HIMS)
$12.8B
Doximity (DOCS)
$11.4B
Tempus AI (TEM)
$11B
IRhythm Technologies (IRTC)
$4.2B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.6B
Privia Health (PRVA)
$2.4B
10x Genomics (TXG)
$1.7B
Schrodinger (SDGR)
$1.7B
Phreesia (PHR)
$1.6B
Clover Health Investments (CLOV)
$1.6B
Azenta (AZTA)
$1.6B
Enovis (ENOV)
$1.6B
Omnicell (OMCL)
$1.3B
Evolent Health (EVH)
$1.1B
Claritev (CTEV)
$686M
Fulgent Genetics (FLGT)
$560M
Standard BioTools (LAB)
$558M
Veradigm (MDRX)
$523M
Butterfly Network (BFLY)
$514M
Talkspace (TALK)
$422M
Outset Medical (OM)
$312M
Health Catalyst (HCAT)
$268M
Nyxoah SA (NYXH)
$265M
SOPHiA GENETICS SA (SOPH)
$241M
CapsoVision (CV)
$198M
Zepp Health (ZEPP)
$165M
KORU Medical Systems (KRMD)
$162M
American Well (AMWL)
$136M